APCI: To Reduce Prescription Drug Costs, Congress Must Fix America’s PBM Problem
APCI warns that while Congress’s drug pricing proposals make progress, they fall short by failing to address the root problem: anti-competitive PBM practices driving costs and limiting patient access.
